Dental and Medical Problems

Dent Med Probl
Journal Impact Factor (JIF 2024) – 3.9
Journal Citation Indicator (JCI 2024) - 1.36
Scopus CiteScore (2024) – 5.0 (CiteScore Tracker – 5.8)
Index Copernicus Value (ICV 2024) – 178.25
MNiSW – 70 pts
ISSN 1644-387X (print)
ISSN 2300-9020 (online)
Periodicity – bimonthly


 

Download original text (EN)

Dental and Medical Problems

2026, vol. 63, nr 2, March-April, p. 483–496

doi: 10.17219/dmp/191308

Publication type: review

Language: English

License: Creative Commons Attribution 3.0 Unported (CC BY 3.0)

Download citation:

  • BIBTEX (JabRef, Mendeley)
  • RIS (Papers, Reference Manager, RefWorks, Zotero)

Cite as:


Alyafei S, Joseph B, Adam A, Anil S. Association between periodontal disease and rheumatoid arthritis: A systematic review and meta-analysis. Dent Med Probl. 2026;63(2):483–496. doi:10.17219/dmp/191308

Association between periodontal disease and rheumatoid arthritis: A systematic review and meta-analysis

Seham Alyafei1,B,C,D,F, Betsy Joseph2,3,A,C,D,F, Aishah Adam1,B,C,D,F, Sukumaran Anil4,5,A,D,E,F

1 Hamad Medical Corporation, Doha, Qatar

2 Department of Oral and Maxillofacial Diseases, University of Helsinki, Finland

3 Department of Periodontology, Saveetha Dental College and Hospitals, Saveetha Institute of Medical and Technical Sciences (SIMATS), Chennai, India

4 Faculty of Dentistry, Chulalongkorn University, Bangkok, Thailand

5 Global Research Cell, Dr. D. Y. Patil Dental College and Hospital, Dr. D. Y. Patil Vidyapeeth, Pimpri, Pune (Deemed to be University), India

Graphical abstract


Graphical abstracts

Highlights


  • This systematic review and meta-analysis demonstrate a strong positive association between periodontitis and rheumatoid arthritis (RA), with RA patients showing an approx. 11-fold higher risk of periodontitis (OR = 11.37; 95% CI: 4.22–30.61; p < 0.01).
  • Clinical attachment loss (CAL) was the most consistently affected periodontal parameter, and the majority of the included studies reported an association between RA and moderate-to-severe periodontitis.
  • Shared risk factors, including smoking, vitamin D deficiency, female sex, advancing age, and elevated anti-Porphyromonas gingivalis antibody titers, may contribute to the relationship between both conditions.
  • The certainty of evidence was rated as low to moderate (GRADE), highlighting the need for well-designed longitudinal and population-based studies using standardized diagnostic criteria.
  • The findings support integrated dental–rheumatologic care, with routine periodontal screening in patients with RA potentially enabling earlier identification of at-risk individuals and improved disease management.

Abstract

This systematic review and meta-analysis aimed to evaluate the association between periodontitis and rheumatoid arthritis (RA) in middle-aged populations.

The study followed the Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) 2020 guidelines. A comprehensive search of major electronic databases was conducted for studies published between 2013 and 2023. In addition, a manual search was performed to identify relevant studies examining an association between these 2 conditions. The Newcastle–Ottawa scale was used to assess the risk of bias for the included cross-sectional and case–control studies. The certainty of evidence was evaluated using the Grading of Recommendations Assessment, Development and Evaluation (GRADE) analysis, and a meta-analysis of eligible studies was conducted.

A total of 11 articles were included in the systematic review, with 9 incorporated into the meta-analysis. A statistically significant positive association was observed between periodontitis and RA for clinical attachment loss (CAL). The GRADE assessment indicated low to moderate level of certainty across studies, indicating strong evidence regarding clinical parameters. The meta-analysis showed a high overall odds ratio (OR) (OR = 11.37; 95% confidence interval (95% CI): 4.22–30.61; p < 0.01), suggesting that patients with RA have a significantly higher risk of developing periodontitis.

In conclusion, this systematic review and meta-analysis identified a positive association between periodontitis and RA. However, the GRADE analysis highlights the need for clinical and longitudinal studies with extended follow-up periods to further clarify this relationship and account for potential confounding factors.

Keywords: periodontitis, meta-analysis, rheumatoid arthritis, rheumatoid factors, GRADE analysis

Introduction

Periodontitis is a chronic inflammatory disease result­ing from a bacterial infection that can potentially initiate and increase systemic levels of various cytokines.1 Recent advancements in periodontology have discovered an association between periodontitis and systemic diseases such as diabetes, myocardial infarction, stroke, arterio­sclerosis, Alzheimer’s disease, osteoporosis, and rheuma­toid arthritis (RA) in adults.

Rheumatoid arthritis and periodontitis are chronic inflammatory conditions that share similar inflammatory mediators, including interleukin (IL)-1β, IL-6 and tumor necrosis factor-alpha (TNF-α).2 Moreover, both diseases are known to impact connective tissue degradation. Rheumatoid arthritis is a systemic autoimmune condition characterized by persistent joint inflammation, resulting in joint destruction and functional loss. Studies have reported that globally, around 1.0% of adults suffer from this condition, with a higher predisposition observed in females (male:female ratio of 1:3). In the United States, around 2% of adults suffer from RA.3, 4, 5 Studies have sug­gested 3 types of disease manifestation among RA patients: self-limited – patients with self-diagnosed RA who do not have symptoms 2–3 years after diagnosis6; easily controlled – conditions managed with non-steroidal anti-inflammatory drugs (NSAIDs)7; and progressive – conditions that typically require second-line therapy and may not fully resolve despite treatment.8

Numerous hypotheses have been developed regarding the correlation between periodontitis and systemic diseases. An intriguing one centers around paraoxonase-1 (PON1), an enzyme with established antiatherogenic and antioxidant activities. Current research investigates the potential role of PON1 in mitigating both dental biofilm formation and periodontitis.9 Many studies have investigated the association between periodontitis and RA.10, 11, 12 While some studies have indicated that periodontitis could be a potential risk factor for RA, others have demonstrated a notable increase in tooth and alveolar bone loss in individuals with longstanding RA.1, 13, 14, 15 Patients diagnosed with periodontitis exhibit a four-fold increase in the likelihood of self-reported RA, which may be related to the beneficial outcomes of non-surgical periodontal therapy (NSPT) in reducing the severity of RA.2, 16, 17 In RA, the synovial membrane produces pro­inflammatory mediators due to systemic immunological failure, leading to synovitis, joint pain and bone dam­age.18, 19 The correlation between RA and periodontitis may be attributed to the association of both conditions with environmental and genetic risk factors, as well as comparable pathobiology.

Periodontitis and RA are characterized by chronic inflammation that leads to increased infiltration of lym­phocytes of the T and B cell types, neutrophils, and monocytes.8, 12 The elevated production of proinflamma­tory cytokines leads to the destruction of joint and alveolar bone tissues in RA and periodontitis, respectively.1, 14 Fibroblasts and lymphocytes increase the expression of receptor activator of nuclear factor-κB ligand (RANKL) during osteoclast formation in both conditions. Auto­immunity to citrullinated proteins has been suggested to contribute to the relationship between RA and inflamma­tion.20 Porphyromonas gingivalis is a significant periodonto­pathogen found in the subgingival plaque. It demon­strates the distinctive capability of citrullinating proteins, thereby accelerating the autoimmune response in RA.21, 22

Both conditions share a common etiology, pathology, immunogenetic background, and pathways of bone cartilage destruction. Additionally, RA and severe periodontal disease are associated with lower oral health-related quality of life (OHRQoL) scores.23 Various studies have also proposed NSPT for these conditions.16, 18, 19 This may be evidenced by the ability of NSPT to reduce disease activity score-28 with C-reactive protein (DAS28-CRP), erythrocyte sedimentation rate (ESR) and anticitrullinated protein antibody (ACPA) levels in serum.24 None­theless, very limited literature shows this bidirectional association, especially in middle-aged adults. The National Health and Nutrition Examination Survey-I (NHANES-I) showed that individuals with periodontitis or missing teeth presented increased odds of prevalent or incident RA.25 However, most of the results were not statistically significant and lacked dose–response relationships. The observed variations may stem from inconsistent criteria for defining the 2 illnesses. The association between these 2 conditions can be explained in various forms: 1) the role of periodontal pathogens (P. gingivalis, anticyclic citrul­linated peptide (anti-CCP)); 2) common immuno­genetics; 3) common risk factors (smoking, age-related factors, psychological issues).1, 12, 13, 26

Several studies have reported discrepancies regarding the correlation between periodontitis and RA. However, recent reports indicate a significant link (biological and immunological) between these prevalent chronic inflammatory conditions.8, 11, 15 Nonetheless, a potential correlation between the severity of RA and periodontitis cannot be established due to inconclusive evidence. Hence, this systematic review aims to evaluate an association between periodontitis and RA among middle-aged populations.

Material and methods

Focus question

Based on the Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) guidelines 2020, a specific question was structured according to the PECOS (Participants, Exposure, Control, Outcomes, and Study design) framework. The focus question for this systematic review was as follows: Among middle-aged populations (P), is there an association between periodontitis (E) and rheumatoid arthritis (O), compared to healthy individuals (C), in observational studies (S)?

Protocol and registration

The research problem, focus question and criteria for inclusion and exclusion were identified after a preliminary literature review. A protocol was prepared and registered prospectively with PROSPERO (registration No. CRD42023490679).

Eligibility criteria

Studies fulfilling the following criteria were included: participants aged ≥30 years; observational studies; studies reporting risk estimates as odds ratios (ORs) or hazard ratios (HRs) with corresponding 95% confidence intervals (95% CIs) for the association between RA and periodontitis; inclusion of a control group (healthy individuals); diagnosis of periodontitis and RA according to accepted diagnostic criteria; adjustment for potential confounding factors; studies with ≥15 patients per group; mean RA duration of ≥5 years; articles published between 2013 and 2023.

The exclusion criteria were as follows: letters to the editor; commentaries; reviews; case reports; case series; animal studies; in vitro studies; and articles published in languages other than English. If more than 1 paper from the same study was retrieved, both were included when different outcomes were reported. However, if the same result was reported in different studies, the one with the larger sample size and/or non-overlapping cohort analyses was selected for the meta-analysis.

Literature search protocol

The search strategy included published and unpublished articles, and this review employed a two-step procedure for selecting studies. An initial search of PubMed®/MEDLINE was conducted, followed by screening of titles, abstracts and keywords.

The second search utilized keywords and index terms across different databases. PubMed®/MEDLINE, Embase, Scopus, Web of Science, and ProQuest were searched from 2013 to 2023 using various combinations of keywords and Medical Subject Headings (MeSH) terms related to periodontitis and RA. Unpublished articles were searched in the OpenGrey database. Moreover, a manual search and citation chasing were performed in various dental and medical journals. The PubMed® search strat­egy is available from the corresponding author upon rea­sonable request.

Selection of articles

The retrieved articles were imported into EndNote 20 (Clarivate, Philadelphia, USA), and duplicates were removed. The relevant articles were entered into a Microsoft Excel (Microsoft Corp., Redmond, USA) sheet, and the final articles were selected by 2 independent reviewers (SeA, BJ), who examined the titles, abstracts and full texts according to the eligibility criteria. Disagreements between the reviewers were resolved through discussion with a third reviewer (SuA). Intraobserver reliability was assessed, and the value of K-alpha between the reviewers was 0.9.

Data extraction

The data was extracted using tools predesigned for research questions. The following details were extracted: 1) authors/year/country; 2) number of males and females included in the test and control groups; 3) mean age of participants; 4) exposure assessment of periodontitis; 5) outcome assessment of RA; 6) RA clinical parameters; 7) periodontal clinical measures; 8) risk estimates (crude and adjusted): ORs, relative risks and HRs with 95% CIs and p-values, if available; 9) number of RA patients with a history of periodontitis; 10) factors adjusted for in the analysis, e.g., age, smoking status and other inflammatory conditions; and 11) conclusions. The reviewers resolved discrepancies through discussion, and the authors were contacted if any data from the primary study was missing.

Assessment of methodological quality

The methodological quality of the included articles was assessed using the Newcastle–Ottawa quality assessment scale for case–control27 and cross-sectional studies.28 A scoring system was used to evaluate the quality of articles, with 17–18 points indicating high, 12–16 indicating moderate, and <12 suggesting low quality. Eligible studies were assessed for quality by 2 reviewers, and any disagreements were resolved through discussion or by the third reviewer.

Data synthesis and assessment of the quality of evidence

A meta-analysis of the included case–control and cross-sectional articles was conducted, as the included studies possessed similar designs, and the pooling of sta­tistical data yielded a concise outcome. Moreover, the quality of evidence was assessed using the GRADE (Grading of Recommendations Assessment, Development and Evaluation) system.29

Results

Study selection

The primary search identified 15,982 relevant articles, out of which 15,778 papers were found to be duplicates and were removed. The titles and abstracts of the remain­ing 204 articles were screened based on the eligibility cri­teria, and 166 were excluded after careful evaluation. The full texts of the remaining 38 articles were examined, and 27 articles were removed based on their objectives or eligibility criteria. Finally, 11 articles were considered eligible for this systematic review. Figure 1 illustrates the study selec­tion process.

Characteristics of the included studies

This review included 11 primary studies, consisting of 5 case–control and 6 cross-sectional studies comprising 4,055 participants (1,396 males and 2,659 females) (Table 1). The included papers were published between 2013 and 2023 and, originating from different countries (India, USA, China, South Korea, Sweden, Spain, Brazil, and Lithuania), represented various ethnic backgrounds. In most of the included studies, the majority of the participants were females aged ≥40 years. Out of the 11 studies, only 2 studies excluded smokers,11, 30 and 1 study did not mention this criterion.17 Only 5 included studies reported medications used by the patients.17, 31, 32, 33, 34 Most of the studies evaluated periodontal health using validated indices, and RA was diagnosed based on the 1987 (revised) American Rheumatism Association (ARA) criteria and 2010 American College of Rheumatology (ACR)/European League Against Rheumatism (EULAR) criteria for RA.

Clinical parameters defining periodontitis

Ten of the 11 included studies evaluated CAL,11, 12, 17, 30, 31, 33, 34, 35, 36, 37 either alone or in combination with other periodontal indices; 1 study did not assess CAL and recorded only PPD and BOP.32 Five studies evaluated PPD and BOP in combination with CAL.11, 12, 30, 34, 35 The odds of developing periodontitis were higher in patients with RA. However, no significant differences were reported regarding the severity of periodontitis in relation to RA. Secondary parameters recorded included the plaque index, the gingival index, tooth loss, and tooth mobility. Only 5 studies evaluated interexaminer calibration reports.12, 30, 32, 34, 35

Clinical parameters defining rheumatoid arthritis

All the included articles diagnosed RA clinically based on the DAS28 criteria as low, moderate or high. Eight papers reported RA treatment, while others did not mention the therapy. Disease duration was evaluated as a factor associated with the outcome in 6 publications, whereas 5 did not assess disease incidence. Eight studies examined ESR and posterior-anterior hand and wrist radiographs,17, 30, 31, 32, 33, 35, 36, 37 4 reports assessed visual analog scores and tender joint counts to measure the occurrence of RA,12, 30, 34, 35 and 5 studies recorded the CRP levels.12, 30, 34, 35, 36 All the included papers utilized validated measures to record RA clinical parameters.

Association between rheumatoid arthritis and periodontitis

Case–control studies

Moura et al. reported a high frequency of periodonti­tis among individuals with high DAS28 scores (adjusted odds ratio (aOR): 3.12; 95% CI: 1.47–4.26).36 Additionally, a significant correlation between periodontitis, RA and smoking was noted (p < 0.01).36 Adjusted risk esti­mates considered older age, female sex, smoking, and the protective effect of alcohol use. Renvert et al. found that high DAS28-ESR was linked to a composite index for periodontitis (OR: 2.5; 95% CI: 1.5–4.2; p < 0.001).32 Rodríguez-Lozano et al. demonstrated that the DAS28-ESR and DAS28-CRP scores were significantly associated with periodontal clinical measures (aOR: 20.57; 95% CI6.02–70.27; p < 0.001) when adjusted for sex, smoking status, socioeconomic status, annual dental prophylaxis, and osteoporosis.33 Zhao et al. also found DAS28-ESR outcomes to be associated with periodontal clinical measures, revealing significant results (aOR: 10.26; 95% CI: 4.67–22.58).17 Similarly, Joseph et al. found that the DAS28-ESR scores were correlated with CAL, with a rela­tively significant OR when smokers were excluded.30

Cross-sectional studies

Posada-López et al. reported that periodontitis was not associated with RA.37 This study adjusted for confounders such as sex, age, P. gingivalis, diabetes, smoking, osteo­porosis, NSAIDs, corticosteroids, and antihypertensive medication. All periodontal variables and P. gingivalis were negatively correlated with RA biochemical markers (p < 0.05). However, Punceviciene et al. reported a high prevalence of severe periodontitis in RA patients.31 This relationship was significantly associated with higher RA disease activity and lower vitamin D levels in the RA–periodontitis group.31 Similarly, Eriksson et al. found that RA parameters correlated with periodontal clinical measures in a study that included non-smokers.12 Kim et al. reported that DAS28 outcomes were associated with CAL in a cohort that included individuals who smoked.35 Furthermore, Choi et al. noted that DAS28-ESR outcomes were correlated with CAL and significantly elevated ORs.34 Dev et al. also documented that the American Rheumatism Association (ARA) 1988 criteria were associated with periodontal clinical measures in a study in non-smokers, where periodontitis was evaluated using the community periodontal index (CPI) and CAL was assessed based on the World Health Organization (WHO) guidelines.11

To summarize, the increased risk of periodontitis was observed in RA patients in 10 studies, and 1 study showed no correlation between the 2 conditions.37 Additionally, 10 studies demonstrated an association between moderate to severe forms of periodontitis in RA patients. Six papers mentioned smoking, vitamin D deficiency and alcohol consumption as risk factors associated with periodontal health and RA.17, 32, 33, 35, 36, 37 Three studies demonstrated anti-P. gingivalis antibody titers and reported a positive association with CAL, PPD and BOP in patients with RA.12, 30, 35 One study noted a significantly higher risk of periodontitis (p = 0.01) among obese females with RA.36 However, 1 report showed no association between the severity of periodontitis in RA patients.37 Table 1 and Table 2 illustrate the relevant findings of the included studies.

Risk of bias analysis

The Newcastle–Ottawa scale was employed to evaluate the risk of bias in the included case–control (Table 3) and cross-sectional studies (Table 4), analyzing case selection, comparison and outcome criteria. Out of the 5 case–control studies, the case and control selection domains scored low, while the comparison and outcome domains achieved higher scores. Accordingly, 1 study was identified as having a high risk of bias,32 and 4 studies had a low risk of bias.17, 30, 33, 36 Similarly, in cross-sectional studies, one study was of poor quality,11 2 were of moderate quality,34, 37 and 3 studies were classified as having a low risk of bias.12, 31, 35

GRADE evaluation

The GRADE analysis reported low certainty of evidence in the analyzed case–control studies on the association between periodontitis and RA (Table 5). Meanwhile, cross-sectional studies demonstrated moderate certainty of evidence. The findings of the GRADE analysis indicate that more clinical and longitudinal studies are required to establish an association between both conditions.

Meta-analysis results

The results of the meta-analysis revealed high het­erogeneity among the included studies (I2 = 95%), and a high overall OR between the groups (OR = 22.76, 95% CI: 6.26–82.70; p < 0.001) (Figure 2A). Sensitivity analysis of the included studies also showed a high OR for the development of periodontitis in RA patients (OR = 11.37, 95% CI: 4.22–30.61) (Figure 2B). Figure 3A represents the overall analysis of cross-sectional studies, which revealed high heterogeneity (I2 = 91%). The overall OR between the groups was 5.34 (95% CI: 2.28–12.51), which was statistically significant (p < 0.001). Overall, sensitivity analysis of the included cross-sectional studies yielded an OR of 7.52 (95% CI: 2.95–19.14), demonstrating a 3 times higher risk of developing periodontitis in patients with RA (Figure 3B). In the context of the 5 studies that were considered in this analysis, only 1 study37 concluded that the effect in question was not significant. The subgroup analysis was not performed, as the authors’ primary focus was on assessing the overall association.

Discussion

To the best of our knowledge, this is the first systematic review to critically analyze and synthesize the available literature on the association between periodontal disease and RA. The results of this study indicate a statistically significant positive association between periodontal disease and RA. According to the results of the meta-analysis, there is an 11.37-fold higher risk of developing periodontitis in patients with RA. However, the GRADE analysis reported low to moderate certainty of evidence, suggesting that more research is needed on this association.

Previous studies have systematically evaluated the association between periodontitis and RA.1, 10, 11, 38, 39 Based on the selection criteria, 11 articles (5 case–control and 6 cross-sectional studies) were included in this systematic review, with 9 articles being incorporated into the meta-analysis. The studies showed a positive association between periodontitis and RA, as 10 out of 11 papers demonstrated a strong correlation. The meta-analysis of cross-sectional studies revealed similar findings. A systematic review and meta-analysis by Kaur et al. showed a significant association between the conditions in 17 out of 19 studies (examining various RA-related factors and periodontitis).40 Another systematic review conducted by Kriauciunas et al. found a link between oral bacterial growth and RA.41 Agnihotri and Gaur reported significantly more severe CAL in their systematic review of elderly patients with RA.42 In a recent scoping review, Nik-Azis et al. found that seropositive RA patients had higher odds of developing chronic periodontitis than the control group.43

The meta-analysis of cross-sectional studies indicated that there is a 5-fold increased risk for RA in patients with moderate to severe periodontitis (95% CI: 2.28–12.35; p = 0.01). The results also indicate that an inverse relationship may exist between the risk ratio of RA and periodontitis. The results of this review support the relationship between these 2 variables. However, given the small number of point estimates available in this analysis, there was a lack of statistical significance rather than an absence of an association. Similarly, in their meta-analysis, Del Rei Daltro Rosa et al.reported a reduction in the RA score index (mean difference = −1.81) in patients treated for periodontitis.44 The risk estimate was lower than that reported in the current study. In the present review, we considered the studies included in the paper of Del Rei Daltro Rosa et al., although some of them could not be quantitatively synthesized. Moreover, the mentioned review included prospective and cross-sectional studies, whereas the current review focused primarily on cross-sectional evidence.

Rheumatoid arthritis is a risk factor for periodontal dis­ease.40 This relationship can be attributed to a possible link between systemic and concurrent alveolar bone resorption in RA and periodontitis. As systemic bone min­eral density declines, for instance in RA, a simultaneous decrease occurs in the density of the maxillary and man­dibular arches.43 This increases bone fragility, inflamma­tion and fracture risk. The majority of studies conducted on middle-aged adults have shown a positive association between RA and periodontal disease, which could be attributed to estrogen-related bone remodeling that increases with age.42 Additionally, estrogen deficiency plays a mediating role in this association, contributing to inflammation and increasing the risk of both periodontitis and RA.12, 44

The clinical presentation of periodontitis may not accurately indicate the presence of P. gingivalis, as not all cases are associated with this bacterium. In some instances, the administration of antibiotics in conjunction with mechanical debridement does not result in substantial improvement for the treatment of chronic periodontitis.45 The presence of various periodontal pathogens, such as Aggregatibacter actinomycetemcomitans, highlights the need for improved study designs that consider the specific bacteria present in the subgingival microbiota.20, 26, 39, 46 Using an objective measurement of periodontal disease, such as quantifying the percentage of inflamed or ulcerated surface area, would address the issue of inconsistent definitions of periodontitis.15, 47, 48

Despite promising results, heterogeneity was observed among the included studies regarding the prevalence and severity of periodontal disease in RA-positive patients. In a cohort study of US veterans, periodontitis patients with RA were associated with the presence of ACPAs.49 However, no significant association was found between peri­odontal disease, ACPA-positive RA patients and healthy controls.50 In a Korean study, the authors indicated a posi­tive association between periodontal inflammation and ACPA levels.35 In a Japanese population cohort study designed to investigate this association, increased periodontal inflammation was reported in patients with sero­positive RA as the level of ACPA rose above 2.34.51, 52 Choi et al. reported increased ACPA levels in patients with severe periodontitis.34 By contrast, 2 studies on cohorts from Sweden and Malaysia found no association between ACPA levels and periodontal health in RA patients.39, 50

The fundamental involvement of periodontal disease with the presence of salivary biomarkers is the basis for the hypothesized relationship between periodontitis and RA. Similar relationships have been studied using novel salivary adipokine levels (e.g., omentin-1). These molecules have the potential to serve as diagnostic tools to assess the progression of periodontal disease and treatment effectiveness.53 However, the epidemiological evidence supporting this association is currently equivocal. These conflicts could be attributed to differences in study design and the selection of comparison groups (healthy controls, osteoporosis, osteoarthritis patients). Most of the included studies investigating this relationship did not specify the type and subsets of RA, even though these are important criteria for establishing an association between both conditions. The need for more specific and standardized criteria for defining periodontal disease and RA, inadequate information on confounding factors, and differences in eligibility criteria can also contribute to the conflicting evidence. Three included studies used data from hospital-based registries, while 2 studies employed national registries as the sample population. Such data provides concrete results due to larger sample sizes but may lack detailed information on confounding factors and associated diseases.

Limitations

The validity of the meta-analysis reported in this review is contingent upon the strength of the association between the 2 conditions – periodontitis and RA. Some studies have noted statistically significant associations between these 2 conditions, while others showed no significant correlations. Including such studies in our meta-analysis increases the validity of the findings and provides a more robust estimate of the association. However, the results of the meta-analysis should be interpreted carefully, as the inclusion of observational studies increases the risk of bias. The studies included in our review varied in methodological quality, resulting in differences in the strength of evidence. Well-controlled, population-based and clinical (molecular epidemiology) studies are needed to confirm the immunological and biological links between RA and periodontal disease. Future studies on this topic should follow the STROBE (Strengthening the Reporting of Observational Studies in Epidemiology) guidelines to facilitate the assessment of study strengths and limitations, as well as the generalizability of findings. Secondly, the review did not specifically consider severe periodontitis, as it is challenging to recruit patients with this condition. The majority of the included studies used convenience sampling methods, which pose a high risk of bias. Furthermore, although sex, age, smoking status, and RA treatment were considered in many studies, these parameters were not reported in detail. Hence, it was challenging to draw definitive conclusions on the role of potential confounding factors.

Conclusions

The current systematic review and meta-analysis found a positive association between periodontitis and RA. Moreover, some studies reported that patients diagnosed with RA present higher levels of salivary biomarkers and microbial load than healthy controls. The results of the GRADE analysis indicate the need for longitudinal clinical studies with longer follow-up durations to compre­hensively evaluate this association and elucidate the potential role of confounding factors. Overall, the findings indicate that individuals diagnosed with RA demonstrate an increased risk of developing periodontal disease when compared to the general population. However, significant heterogeneity was observed across the included studies with respect to study populations, definitions of periodontal disease and RA assessments. Further research using standardized disease criteria and measurements is warranted. Understanding the interrelationship between periodontitis and RA may facilitate the identification of shared risk factors and disease mechanisms. Ultimately, clarifying this association has implications for the early identification of at-risk patients, preventive strategies and integrated treatment approaches that bridge oral health and chronic inflammatory disease management. The results of this review must be interpreted with caution, given the high heterogeneity among the included studies. Further research is necessary to clarify the extent and underlying nature of the periodontitis–RA relationship, as suggested by this initial evidence synthesis.

Ethics approval and consent to participate

Not applicable.

Data availability

The datasets generated and/or analyzed during the current study are available from the corresponding author on reasonable request.

Consent for publication

Not applicable.

Use of AI and AI-assisted technologies

Not applicable.

Tables


Table 1. Characteristics of the included studies

Study

Country

Study design

Participants, n

Sex (M/F), n

Age
[years]

Results

Conclusions

Posada-López et al.
2023
37

USA

cross-sectional

75
(PD without RA: 21;
PD+RA: 33;
reduced periodontium with RA: 21)

20/55

52.8
(50.3–55.3)

In RA patients, milder periodontal conditions were observed. Patients without PD displayed the highest ACPA levels. Factors like age, P. gingivalis, diabetes, smoking status, osteoporosis, and medication were not significantly correlated with RA (p < 0.05).

PD was not associated with RA. Furthermore, no correlation emerged between periodontal clinical parameters and RA biochemical markers.

Moura et al.
2021
36

Brazil

case–control

471
(RA: 157;
controls: 314)

145/326

49.13 ±7.88

The study demonstrated a significantly higher frequency (p < 0.001), severity (p = 0.006) and extent (p = 0.018) of periodontitis in RA patients compared to controls. RA demonstrated an OR of 2.53 (95% CI: 1.24–3.86, p < 0.001) for PD, while PD showed an OR of 3.12 (95% CI: 1.47–4.26, p < 0.001) for RA.

Individuals with RA have a high frequency of PD. There is a significant correlation between the occurrence, severity and extent of PD, RA and smoking habits.

Punceviciene et al.
2021
31

Lithuania

cross-sectional

93
(RA+PD: 63;
RA only: 30)

14/79

54.01 ±11.01

29% of RA patients had severe PD. Those with moderate–severe PD showed higher DAS28-CRP scores (4.49 ±1.22 vs. 3.86 ±1.58, p = 0.033). Lower vitamin D levels were found in RA+PD patients with severe PD (39.61 ±17.12 vs. 52.07 ±18.23 nmol/L, p = 0.031).

RA patients exhibited a notable prevalence of severe PD, with a significant association between severe PD and elevated RA disease activity. Additionally, lower vitamin D levels were noted in the RA+PD group.

Renvert et al.
2020
32

Sweden

case–control

375
(RA: 126;
controls: 249)

147/228

70 ±6.6 (RA);
70 ±7.1 (controls)

The RA group had a significantly higher prevalence of PD (61.1%) than the control group (33.7%) (p = 0.001). Logistic regression showed associations between RA and BMI > 25 (OR: 6.2), PD (OR: 2.5) and female sex (OR: 2.3).

The RA group exhibited a higher prevalence of PD than controls. Patients with RA had higher odds of developing PD (OR: 2.5, 95% CI: 1.5–4.2, p < 0.001), especially among females or obese individuals.

Rodríguez-Lozano et al.
201933

Spain

case–control

344
(RA: 187;
controls: 157)

96/248

54.4 ±10.8 (RA); 55.5 ±23.7 (controls)

A significant association was found between PD and RA (aOR: 20.57, 95% CI: 6.02–70.27, p < 0.001). RA patients showed worse periodontal parameters than controls (p < 0.001). The severity of PD was correlated with RA disease activity (aOR: 2.66, 95% CI: 1.24–5.74, p = 0.012).

A strong correlation persists between PD and RA, remaining significant despite controlling for other variables. This association is notably stronger among individuals with severe PD and higher RA activity.

Eriksson et al.
2019
12

Sweden

cross-sectional

40
(RA without PD: 10; RA+PD: 30)

5/35

50 ±14 (RA without PD);
64 ±7.8 (RA+PD)

Most patients (75%) had moderate or severe PD, while others were diagnosed with no or mild PD. ACPA positivity was more prevalent in moderate/severe PD (86%) when compared to no/mild cases (50%). There were significant differences in plaque microbial composition.

RA patients with moderate/severe PD exhibited significant associations with ACPA positivity, altered subgingival microbial profiles and elevated inflammatory mediator levels.

Zhao et al.
2019
17

China

case–control

237
(RA: 128;
controls: 109)

33/204

44.36 ±8.16

RA patients exhibited significantly worse periodontal health, with a 10.26-fold
increased risk of periodontitis after adjusting for factors. Independent associations included DAS28, ESR, educational level, and anti-CCP positivity.

RA patients demonstrate higher odds of developing PD.

Kim et al.
2018
35

South Korea

cross-sectional

346
(RA: 260;
controls: 86)

45/301

58.13 ±11.65 (RA);
58.08 ±12.17 (controls)

The RA group showed significantly higher periodontal indices (p < 0.05), except for teeth count. BOP correlated with DAS28, RA duration, ESR, anti-Pg, and anti-CCP titers. CAL and the severity of PD were associated with anti-Pg titers.

GI, BOP and PPD correlated positively with RA indices, but CAL did not. The anti-Pg titer correlated positively with PPD, BOP, CAL, and PD severity.

Choi et al.
2016
34

South Korea

cross-sectional

352
(RA: 264;
controls: 88)

44/308

58.2 ±12.0 (RA); 58.2 ±11.6 (controls)

RA patients had a higher prevalence of moderate/severe PD than controls (63.6% vs. 34.1%, p < 0.001). BOP correlated positively with DAS28 (r = 0.128, p = 0.041) and RA disease duration (r = 0.211, p = 0.001).

The prevalence of moderate/severe PD was higher in RA patients compared to controls.

Joseph et al.
2013
30

India

case–control

212
(RA: 100;
controls: 112)

50/162

46.54 ±8.5 (RA); 45.91 ±9.76 (controls)

Significant differences in GI, OHI-S, PPD, CAL, ESR, and CRP levels were observed between RA and non-RA groups (p < 0.05). However, there was no association between disease activity and PD severity in patients with RA.

The occurrence and severity of PD were higher in RA subjects compared to controls.

Dev et al.
2013
11

India

cross-sectional

1,520
(RA+PD: 852;
controls: 668)

802/718

Among patients referred for periodontal treatment, the prevalence of RA was 4.4%. Females (3.2%) and those aged >50 years (3.5%) had a significantly higher prevalence of RA (p < 0.001). Odds of RA in females were nearly 3 times higher compared to males (OR = 2.81, p < 0.05).

Individuals with moderate to severe periodontal disease are at higher risk of developing RA, and vice versa.

ACPA – anticitrullinated protein antibody; anti-CCP – anticyclic citrullinated peptide antibody; anti-Pg – antibody against P. gingivalis; aOR – adjusted odds ratio; BMI – body mass index; BOP – bleeding on probing; CAL – clinical attachment level; CRP – C-reactive protein; DAS28 – disease activity score-28; ESR – erythrocyte sedimentation rate; GI – gingival index; OHI-S – oral hygiene index-simplified; OR – odds ratio; PD – periodontitis; P. gingivalis – Porphyromonas gingivalis; PPD – probing pocket depth; RA – rheumatoid arthritis; 95% CI – 95% confidence interval.
Table 2. Risk estimates of the included studies

Study

Inclusion of smokers

Exposure
(definition and assessment of periodontitis)

Outcome (definition and assessment of RA)

RA clinical parameters

Periodontal clinical measures

Risk estimates and adjusted risk estimates

RA patients with a history of periodontitis, n

Factors adjusted for in the analysis

Posada-López et al.37

yes

2 or more non-adjacent interdental sites with loss of CAL, PPD ≥ 4 mm and BOP

ACR; DAS28-CRP ≥ 3.2

ACPA [U/mL]:
PD (Me (IQR)): 0.5 (0.5–0.65)
PD+RA: 98.6 (10.9–200.0)
non-PD+RA: 45.8 (8.2–507.4) (p < 0.001)

RF [U/mL]:
PD: 15.0 (0.0–0.0)
PD+RA: 72.6 (9.0–144.2)
non-PD+RA: 157.9 (16.0–268.0) (p < 0.001)

PD (stage III):
PD: 5 (23.8%)
PD+RA: 19 (57.6%)

PD (stage IV):
PD: 16 (76.2%)
PD+RA: 12 (36.4%)

crude OR: 0.078 (0.1–0.3)

31

sex, age, P. gingivalis, diabetes, smoking, osteoporosis, NSAIDs, corticosteroids, antihypertensive medication

Moura et al.36

yes

stage II: ≥2 interproximal sites with CAL of 3–4 mm and PPD ≤5 mm

ACR; DAS28

N/A

CAL [mm]:
test: 4.8 ±1.8
control: 4.0 ±1.5

crude OR: 2.64 (1.78–3.94); p < 0.0001
aOR: 3.12 (1.47–4.26)

84

older age, female sex, smoking, protective effect of alcohol use

Punceviciene et al.31

yes

2018 AAP/EFP classification

ACR/EULAR; DAS28-CRP

DAS28:
total: 4.19 ±1.43
RA+PD: 4.37 ±1.28
RA only: 3.82 ±1.65 (p = 0.08)

CRP [mg/L]:
total: 12.08 ±21.5
RA+PD: 13.82 ±24.44
RA only: 8.44 ±12.99 (p = 0.98)

severe PD (stages III–IV): 27 (29.0%)

not mentioned

27

not mentioned

Renvert et al.32

yes

PPD and BOP; CAL not assessed

ACR; DAS28-ESR

N/A

RA (n = 126): 61 patients with PD (48%)
controls (n = 249): 96 patients with PD (38.6%);
p = 0.001

crude OR (PD: composite index): 2.5 (1.5–4.2); p < 0.001

61

not mentioned

Rodríguez-Lozano et al.33

yes

CAL and PPD (based on Tonetti and Claffey criteria, 2005)

DAS28-ESR or DAS28-CRP

N/A

CAL [mm]:
RA: 3.99 ±1.27
controls: 3.34 ±1.03

crude OR (periodontitis): 14.75 (5.66–34.4); p < 0.001
aOR: 20.57 (6.02–70.27); p < 0.001

182

sex, smoking, socioeconomic
status, annual dental prophylaxis, osteoporosis

Eriksson et al.12

yes (no current smokers but former smokers)

PPD, CAL and BOP at 6 sites per tooth

DAS28-CRP

DAS28:
RA without PD: 2.7 ±1.5
RA+PD: 3.3 ±1.4

ACPA-positive:
RA without PD: 5 ±50
RA+PD: 25 ±86

CAL ≥ 4 mm:
RA without PD: 0.5 ±0.5
RA+PD: 10 ±6.7

not mentioned

30

sex, age, smoking habits

Zhao et al.17

not mentioned

AAP (Armitage et al., 2003 classification)

DAS28-ESR

DAS28-ESR:
RA+PD: 4.03 ±1.38
RA without PD: 3.64 ±1.46 (p = 0.148)

DAS28-CRP:
RA+PD: 12.95 ±15.13
RA without PD: 9.29 ±8.13 (p = 0.149)

CAL [mm]:
RA: 3.57 ±1.59
controls: 2.11 ±1.13; p < 0.001

crude OR: 4.68 (2.70–8.11)
aOR: 10.26 (4.67–22.58)

87

age, education, BMI

Kim et al.35

yes

CAL (AAP, 1999)

DAS28

DAS28:
RA: 3.62 ±1.35

ACPA [U/mL]:
RA: 67.5

CAL [mm]:
RA: 3.25 ±0.74
controls: 2.91 ±0.52

not mentioned

not mentioned

not mentioned

Choi et al.34

yes

CAL (AAP, 1999)

DAS28-ESR

DAS28:
RA: 3.3 ±1.4

ACPA [U/mL]:
RA: 69.1

CAL [mm]:
RA: 3.25 ±0.73
controls: 2.90 ±0.51

crude OR: 3.38 (2.50–4.57)

not mentioned

not mentioned

Joseph et al.30

no

CAL (AAP, 1999)

DAS28-ESR

not mentioned

CAL [mm]:
RA: 2.88 ±1.10
controls: 0.98 ±1.04

rOR: 3.05

58

not mentioned

Dev et al.11

no

CPI with CAL based on the WHO guidelines (1997)

ARA, 1988

not mentioned

not mentioned

not mentioned

572

not mentioned

AAP – American Academy of Periodontology; ACR – American College of Rheumatology; ARA – American Rheumatism Association;
EFP – European Federation of Periodontology; EULAR – European League Against Rheumatism; IQR – interquartile range; Me – median;
NSAIDs – non-steroidal anti-inflammatory drugs; RF – rheumatoid factor; rOR – reporting odds ratio; WHO – World Health Organization.
Table 3. Assessment of the risk of bias for case–control studies (Newcastle–Ottawa scale)27

Domain

Item

Study

Joseph et al.30

Zhao et al.17

Rodríguez-Lozano et al.33

Renvert et al.32

Moura et al.36

Selection

adequacy of case definition

**

**

**

*

**

representativeness of cases

**

**

**

*

**

selection of controls

**

**

**

*

**

definition of controls

**

**

**

*

**

Comparability

comparability of cases and controls based on design or analysis

**

**

**

**

**

Exposure

ascertainment of exposure

**

**

**

*

**

same method of ascertainment for case and control groups

_

_

_

_

_

non-response rate

*

_

_

*

*

Quality

good

good

good

poor

good

Table 4. Assessment of the risk of bias for cross-sectional studies (Newcastle–Ottawa scale)27

Domain

Item

Study

Dev et al.11

Choi et al.34

Kim et al.35

Eriksson et al.12

Punceviciene et al.31

Posada-López et al.37

Selection

representativeness of cases

**

**

**

**

**

**

sample size

*

*

*

*

*

*

non-response rate

_

_

_

*

*

_

ascertainment of the screening/surveillance tool

_

_

_

_

_

_

Comparability

assessment of potential confounders (subgroup or multivariable analysis)

_

**

**

**

**

**

Outcome

assessment of the outcome

*

**

**

**

**

**

statistical test

**

**

**

**

**

**

Quality

poor

moderate

good

good

good

moderate

Table 5. Grading of Recommendations Assessment, Development and Evaluation (GRADE) analysis

Certainty assessment

Patients with RA/healthy controls, n

Effect

Certainty (GRADE)

Importance

category

studies, n
(design)

risk of bias

inconsistency

indirectness

imprecision

other considerations

relative effect

assumed baseline risk

anticipated absolute effect (95% CI)

periodontal health of patients with and without RA (case–control studies)

5
(observational)

seriousa

seriousb

not serious

not serious

There was a strong association between both conditions. Plausible residual confounding would reduce the demonstrated effect.

5,060/5,759

OR: 22.76
(95% CI: 6.26–82.70)

10%

5,060 more per 10,000 (159–383 more)

⨁⨁◯◯
low

important

33%

3,868 more per 10,000 (2,773–4,755 more)

periodontal health of patients with and without RA (cross-sectional studies)

6
(observational)

seriousa

seriousb

not serious

not serious

Plausible residual confounding would suggest a spurious effect, while no effect was observed.

6,027/12,741

OR: 5.34
(95% CI: 2.28–12.51)

10%

1,281 more per 10,000 (124–1,574 more)

⨁⨁⨁◯
moderate

important

33%

2,327 more per 10,000 (282–2,721 more)

a risk of bias rated as serious owing to the predominantly observational study design, the use of convenience sampling and incomplete reporting of confounders in several included studies; b inconsistency rated as serious because of substantial statistical heterogeneity (I2 = 87–95%) across the included studies.

Figures


Fig. 1. Study selection process
Fig. 2. Forest plot of the effect size for the association between periodontitis and rheumatoid arthritis (RA) in the included studies
A. Overall analysis; B. Sensitivity analysis.
95% CI – 95% confidence interval; df – degrees of freedom; M–H – Mantel–Haenszel.
Fig. 3. Forest plot of the effect size for the association between periodontitis and rheumatoid arthritis (RA) in the included cross-sectional studies
A. Overall analysis; B. Sensitivity analysis.

References (53)

  1. Georgiou TO, Marshall RI, Bartold PM. Prevalence of systemic diseases in Brisbane general and periodontal practice patients. Aust Dent J. 2004;49(4):177–184. doi:10.1111/j.1834-7819.2004.tb00070.x
  2. Yang NY, Wang CY, Chyuan IT, et al. Significant association of rheumatoid arthritis-related inflammatory markers with non-surgical periodontal therapy. J Formos Med Assoc. 2018;117(11):1003–1010. doi:10.1016/j.jfma.2017.11.006
  3. Pitones-Rubio V, Chávez-Cortez EG, Hurtado-Camarena A, González-Rascón A, Serafín-Higuera N. Is periodontal disease a risk factor for severe COVID-19 illness? Med Hypotheses. 2020;144:109969. doi:10.1016/j.mehy.2020.109969
  4. Potempa J, Mydel P, Koziel J. The case for periodontitis in the pathogenesis of rheumatoid arthritis. Nat Rev Rheumatol. 2017;13(10):606–620. doi:10.1038/nrrheum.2017.132
  5. Ribeiro J, Leão A, Novaes AB. Periodontal infection as a possible severity factor for rheumatoid arthritis. J Clin Periodontol. 2005;32(4):412–416. doi:10.1111/j.1600-051X.2005.00689.x
  6. O’Sullivan JB, Cathcart ES. The prevalence of rheumatoid arthritis. Follow-up evaluation of the effect of criteria on rates in Sudbury, Massachusetts. Ann Intern Med. 1972;76(4):573–577. doi:10.7326/0003-4819-76-4-573
  7. Pincus T, Marcum SB, Callahan LF. Longterm drug therapy for rheumatoid arthritis in seven rheumatology private practices: II. Second line drugs and prednisone. J Rheumatol. 1992;19(12):1885–1894. PMID:1294735.
  8. Cotti E, Schirru E, Acquas E, Usai P. An overview on biologic medications and their possible role in apical periodontitis. J Endod. 2014;40(12):1902–1911. doi:10.1016/j.joen.2014.08.013
  9. Ghorbani P, Rezaei Esfahrood ZR, Foroughi M. Paraoxonase-1, a novel link between periodontitis and ischemic heart disease: A case–control study. Dent Med Probl. 2023;60(1):55–59. doi:10.17219/dmp/152181
  10. de Molon RS, Rossa C Jr., Thurlings RM, Cirelli JA, Koenders MI. Linkage of periodontitis and rheumatoid arthritis: Current evidence and potential biological interactions. Int J Mol Sci. 2019;20(18):4541. doi:10.3390/ijms20184541
  11. Dev YP, Khuller N, Basavaraj P, G S. Rheumatoid arthritis among periodontitis patients in Baddi industrial estate of Himachal Pradesh, India: A cross sectional study. J Clin Diagn Res. 2013;7(10):2334–2337. doi:10.7860/JCDR/2013/6237.3518
  12. Eriksson K, Fei G, Lundmark A, et al. Periodontal health and oral microbiota in patients with rheumatoid arthritis. J Clin Med. 2019;8(5):630. doi:10.3390/jcm8050630
  13. Eriksson K, Nise L, Kats A, et al. Prevalence of periodontitis in patients with established rheumatoid arthritis: A Swedish population based case–control study. PLoS One. 2016;11(5):e0155956. doi:10.1371/journal.pone.0155956
  14. Gleissner C, Willershausen B, Kaesser U, Bolten WW. The role of risk factors for periodontal disease in patients with rheumatoid arthritis. Eur J Med Res. 1998;3(8):387–392. PMID:9707521.
  15. Gonzalez SM, Payne JB, Yu F, et al. Alveolar bone loss is associated with circulating anti-citrullinated protein antibody (ACPA) in patients with rheumatoid arthritis. J Periodontol. 2015;86(2):222–231. doi:10.1902/jop.2014.140425
  16. Takeuchi-Hatanaka K, Koyama Y, Okamoto K, Sakaida K, Yamamoto T, Takashiba S. Treatment resistance of rheumatoid arthritis relates to infection of periodontal pathogenic bacteria: A case–control cross-sectional study. Sci Rep. 2022;12(1):12353. doi:10.1038/s41598-022-16279-z
  17. Zhao R, Gu C, Zhang Q, et al. Periodontal disease in Chinese patients with rheumatoid arthritis: A case–control study. Oral Dis. 2019;25(8):2003–2009. doi:10.1111/odi.13176
  18. Rutger Persson G. Rheumatoid arthritis and periodontitis – inflammatory and infectious connections. Review of the literature. J Oral Microbiol. 2012;4. doi:10.3402/jom.v4i0.11829
  19. Schulz S, Pütz N, Jurianz E, Schaller HG, Reichert S. Are there any common genetic risk markers for rheumatoid arthritis and periodontal diseases? A case–control study. Mediators Inflamm. 2019;2019:2907062. doi:10.1155/2019/2907062
  20. Kobayashi T, Kido JI, Ishihara Y, et al. The KCNQ1 gene polymorphism as a shared genetic risk for rheumatoid arthritis and chronic periodontitis in Japanese adults: A pilot case–control study. J Periodontol. 2018;89(3):315–324. doi:10.1002/JPER.17-0412
  21. Jung ES, Choi YY, Lee KH. Relationship between rheumatoid arthritis and periodontal disease in Korean adults: Data from the Sixth Korea National Health and Nutrition Examination Survey, 2013 to 2015. J Periodontol. 2019;90(4):350–357. doi:10.1002/JPER.18-0290
  22. Kässer UR, Gleissner C, Dehne F, Michel A, Willershausen-Zönnchen B, Bolten WW. Risk for periodontal disease in patients with longstanding rheumatoid arthritis. Arthritis Rheum. 1997;40(12):2248–2251. doi:10.1002/art.1780401221
  23. Posada-López A, Botero JE, Duque-Castaño JD, Ronda-Pérez E, Agudelo-Suárez AA. Oral health-related quality of life in a group of patients with rheumatoid arthritis. Dent Med Probl. 2023;60(1):109–119. doi:10.17219/dmp/149455
  24. Nguyen VB, Nguyen TT, Huynh NCN, Nguyen KD, Le TA, Hoang HT. Effects of non-surgical periodontal treatment in rheumatoid arthritis patients: A randomized clinical trial. Dent Med Probl. 2021;58(1):97–105. doi:10.17219/dmp/131266
  25. Eklund SA, Burt BA. Risk factors for total tooth loss in the United States; longitudinal analysis of national data. J Public Health Dent. 1994;54(1):5–14. doi:10.1111/j.1752-7325.1994.tb01173.x
  26. Gamel EB, Hashim NT, Satti A, Gismalla BG. Salivary TNFα levels in groups of subjects with rheumatoid arthritis and chronic periodontitis. BMC Res Notes. 2017;10(1):34. doi:10.1186/s13104-016-2341-7
  27. Stang A. Critical evaluation of the Newcastle–Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25(9):603–605. doi:10.1007/s10654-010-9491-z
  28. Owens DK, Lohr KN, Atkins D, et al. AHRQ series paper 5: Grading the strength of a body of evidence when comparing medical interventions – agency for healthcare research and quality and the effective health-care program. J Clin Epidemiol. 2010;63(5):513–523. doi:10.1016/j.jclinepi.2009.03.009
  29. Guyatt G, Oxman AD, Akl EA, et al. GRADE guidelines: 1. Introduction–GRADE evidence profiles and summary of findings tables. J Clin Epidemiol. 2011;64(4):383–394. doi:10.1016/j.jclinepi.2010.04.026
  30. Joseph R, Rajappan S, Nath SG, Paul BJ. Association between chronic periodontitis and rheumatoid arthritis: A hospital-based case–control study. Rheumatol Int. 2013;33(1):103–109. doi:10.1007/s00296-011-2284-1
  31. Punceviciene E, Rovas A, Puriene A, et al. Investigating the relationship between the severity of periodontitis and rheumatoid arthritis: A cross-sectional study. Clin Rheumatol. 2021;40(8):3153–3160. doi:10.1007/s10067-021-05661-3
  32. Renvert S, Berglund JS, Persson GR, Söderlin MK. The association between rheumatoid arthritis and periodontal disease in a population-based cross-sectional case–control study. BMC Rheumatol. 2020;4:31. doi:10.1186/s41927-020-00129-4
  33. Rodríguez-Lozano B, González-Febles J, Garnier-Rodríguez JL, et al. Association between severity of periodontitis and clinical activity in rheumatoid arthritis patients: A case–control study. Arthritis Res Ther. 2019;21(1):27. doi:10.1186/s13075-019-1808-z
  34. Choi IA, Kim JH, Kim YM, et al. Periodontitis is associated with rheumatoid arthritis: A study with longstanding rheumatoid arthritis patients in Korea. Korean J Intern Med. 2016;31(5):977–986. doi:10.3904/kjim.2015.202
  35. Kim JH, Choi IA, Lee JY, et al. Periodontal pathogens and the association between periodontitis and rheumatoid arthritis in Korean adults. J Periodontal Implant Sci. 2018;48(6):347–359. doi:10.5051/jpis.2018.48.6.347
  36. Moura MF, Cota LOM, Costa AM, Silva TA, Costa FO. Rheumatoid arthritis associated with the occurrence, severity and extension of periodontitis: A case–control study. J Clin Exp Dent. 2021;13(4):e389–e396. doi:10.4317/jced.57540
  37. Posada-López A, Duque JD, Pineda-Tamayo RA, Bedoya-Giraldo E, Botero JE. Lack of association between periodontitis and rheumatoid arthritis. Reumatol Clin (Engl Ed). 2023;19(3):123–129. doi:10.1016/j.reumae.2022.03.006
  38. Fuggle NR, Smith TO, Kaul A, Sofat N. Hand to mouth: A systematic review and meta-analysis of the association between rheumatoid arthritis and periodontitis. Front Immunol. 2016;7:80. doi:10.3389/fimmu.2016.00080
  39. Eriksson K, Lundmark A, Delgado LF, et al. Salivary microbiota and host-inflammatory responses in periodontitis affected individuals with and without rheumatoid arthritis. Front Cell Infect Microbiol. 2022;12:841139. doi:10.3389/fcimb.2022.841139
  40. Kaur S, White S, Bartold PM. Periodontal disease and rheumatoid arthritis: A systematic review. J Dent Res. 2013;92(5):399–408. doi:10.1177/0022034513483142
  41. Kriauciunas A, Gleiznys A, Gleiznys D, Janužis G. The influence of Porphyromonas gingivalis bacterium causing periodontal disease on the pathogenesis of rheumatoid arthritis: Systematic review of literature. Cureus. 2019;11(5):e4775. doi:10.7759/cureus.4775
  42. Agnihotri R, Gaur S. Rheumatoid arthritis in the elderly and its relationship with periodontitis: A review. Geriatr Gerontol Int. 2014;14(1):8–22. doi:10.1111/ggi.12062
  43. Nik-Azis NM, Mohd N, Mohd Fadzilah F, Mohamed Haflah NH, Mohamed Said MS, Baharin B. Rheumatoid arthritis serotype and synthetic disease-modifying anti-rheumatic drugs in patients with periodontitis: A case–control study. PLoS One. 2021;16(6):e0252859. doi:10.1371/journal.pone.0252859
  44. Del Rei Daltro Rosa CD, de Luna Gomes JM, Dantas de Moraes SL, et al. Does non-surgical periodontal treatment influence on rheumatoid arthritis? A systematic review and meta-analysis. Saudi Dent J. 2021;33(8):795–804. doi:10.1016/j.sdentj.2021.09.007
  45. Zúñiga-Loor D, Parise-Vasco JM, Montesinos-Guevara C. Mechanical debridement combined with amoxicillin and metronidazole compared with mechanical debridement alone for the treatment of chronic periodontitis: An overview of systematic reviews. Dent Med Probl. 2024;61(3):439–446. doi:10.17219/dmp/158925
  46. Beyer K, Zaura E, Brandt BW, et al. Subgingival microbiome of rheumatoid arthritis patients in relation to their disease status and periodontal health. PLoS One. 2018;13(9):e0202278. doi:10.1371/journal.pone.0202278
  47. Rahajoe PS, de Smit M, Schuurmans G, et al. Increased IgA anti-citrullinated protein antibodies in the periodontal inflammatory exudate of healthy individuals compared to rheumatoid arthritis patients. J Clin Periodontol. 2020;47(5):552–560. doi:10.1111/jcpe.13277
  48. Rasch EK, Hirsch R, Paulose-Ram R, Hochberg MC. Prevalence of rheumatoid arthritis in persons 60 years of age and older in the United States: Effect of different methods of case classification. Arthritis Rheum. 2003;48(4):917–926. doi:10.1002/art.10897
  49. Mikuls TR, Payne JB, Yu F, et al. Periodontitis and Porphyromonas gingivalis in patients with rheumatoid arthritis. Arthritis Rheumatol. 2014;66(5):1090–1100. doi:10.1002/art.38348
  50. Mohamad WMW, Jia SK, Ghazali WSW, Taib H. Anti-cyclic citrullinated peptide antibody and periodontal status in rheumatoid arthritis patients. Pak J Med Sci. 2018;34(4):907–912. doi:10.12669/pjms.344.15007
  51. Hashimoto H, Hashimoto S, Muto A, Dewake N, Shimazaki Y. Influence of plaque control on the relationship between rheumatoid arthritis and periodontal health status among Japanese rheumatoid arthritis patients. J Periodontol. 2018;89(9):1033–1042. doi:10.1002/JPER.17-0575
  52. Hashimoto M, Yamazaki T, Hamaguchi M, et al. Periodontitis and Porphyromonas gingivalis in preclinical stage of arthritis patients. PLoS One. 2015;10(4):e0122121. doi:10.1371/journal.pone.0122121
  53. Patil RS, Kalburgi NB, Koregol AC, Vinayaka AM, Puttarevanna T, Hannahson P. Effect of non-surgical periodontal therapy on the salivary levels of omentin-1, a novel adipokine biomarker in periodontitis: A clinico-biochemical study. Dent Med Probl. 2022;59(4):565–571. doi:10.17219/dmp/145593